Similar Search Results

Refunded emission payments and diffusion of NOx abatement technologies in Sweden

Bonilla, Jorge; Coria, Jessica; Mohlin, Kristina; … - In: Ecological economics : the transdisciplinary journal of … 116 (2015), pp. 132-145

Persistent link: https://www.econbiz.de/10011497074

Reimbursement and clinical guidance for pharmaceuticals in Sweden : do health-economic evaluations support decision making?

Anell, Anders; Persson, Ulf - In: The European journal of health economics : HEPAC ; … 6 (2005) 3, pp. 274-279

Persistent link: https://www.econbiz.de/10003114576

Reimbursement and clinical guidance for pharmaceuticals in Sweden

Anell, Anders; Persson, Ulf - In: The European Journal of Health Economics 6 (2005) 3, pp. 274-279

Persistent link: https://www.econbiz.de/10009404270

A comparative analysis of coverage decisions for outpatient pharmaceuticals: Evidence from Denmark, Norway and Sweden

Grepstad, Mari; Kanavos, Panos - In: Health Policy 119 (2015) 2, pp. 203-211

pharmaceuticals in Denmark, Norway and Sweden, following HTA appraisals. A comparative analysis of all outpatient drug appraisals … stakeholders in the three countries were carried out to complement the discussion on HTA processes and reimbursement outcomes … appraisals between Norway and Sweden (free-marginal kappa 0.89). Similarities were found in priority setting principles, mode of …

Persistent link: https://www.econbiz.de/10011190155

The importance of the first generic substitution : evidence from Sweden

Janssen, Aljoscha; Granlund, David - 2022

We analyze changes in the willingness to substitute from prescribed pharmaceuticals to more affordable generic equivalents in response to the first experience with a substitution. Using Swedish individual-level data of prescribed and dispensed pharmaceuticals, we employ a dynamic event study and...

Persistent link: https://www.econbiz.de/10013175464